.. _custom-db:

Custom database configuration
=============================

It is also possible that users use custom databases for the annotation of genomes. Currently, the pipeline only executes BLASTn alignments using the genome as query.
Therefore, the given databases must be files of **target gene sequences in nucleotide** FASTA.

The custom annotation is triggered with the ``--custom_db`` parameter. The pipeline accepts more than one custom database at once, separated by commas, e.g.
``--custom_db db1.fasta,db2.fasta``.

Although simple, the custom database must follow some rules about sequence header format in order to make it possible the summarization of alignments and renderization
of custom reports in HTML format, that shall be available under the ``report_files`` directory.

Sequence header format
----------------------

Sequence headers must follow a 5-field rule separated by "~~~" and spaces. The first 4 fields must be separated by "~~~" and the last one by one space, following the
example shown below:

.. warning::

  Except for the Description field, the first four (DB name, gene name, gene reference and gene product) must be written **whithout** whitespaces.

.. code-block:: bash

    # Sequence header
    >Database_name~~~gene/product_name/alias~~~acc.number_reference_or_identification~~~gene_product  Description

    # An example with a VFDB sequence
    >VFDB~~~(plc)~~~VFG037176(gb|YP_001844723)~~~[Phospholipase_C_(VF0470)]  VFG037176(gb|YP_001844723) (plc) phospholipase C [Phospholipase C (VF0470)]

.. note::

  It is very important to follow this header format in order to make it possible and easier to render summaries and reports of the BLASTn result, such as below:

BLASTn summary example
----------------------

When the header is followed, the summaries and reports are very well rendered such as in this example:

.. code-block:: bash

    SEQUENCE	START	END	STRAND	GENE	COVERAGE	GAPS	%COVERAGE	%IDENTITY	DATABASE	VFDB_ID	PRODUCT	DESCRIPTION
    BNHFPCLP_00473	1	528	+	(rcsB)	1-527/651	2/3	80.8	99.43	VFDB	VFG049018(gb|YP_002920501.1)	[RcsAB_(VF0571)]	 VFG049018(gb|YP_002920501.1) (rcsB) transcriptional regulator RcsB [RcsAB (VF0571)]
    BNHFPCLP_00654	1	629	+	(cpsACP)	1-629/630	0/0	99.84	95.55	VFDB	VFG048985(gb|YP_002920368.1)	[Capsule_(VF0560)]	 VFG048985(gb|YP_002920368.1) (cpsACP) phosphatase PAP2 family protein [Capsule (VF0560)]
    BNHFPCLP_00676	1	1167	+	(ugd)	1-1167/1167	0/0	100.0	96.92	VFDB	VFG048797(gb|YP_002920350.1)	[Capsule_(VF0560)]	 VFG048797(gb|YP_002920350.1) (ugd) UDP-glucose 6-dehydrogenase [Capsule (VF0560)]
    BNHFPCLP_00680	1	741	+	(wzt)	1-741/741	0/0	100.0	99.46	VFDB	VFG049084(gb|YP_002920347.1)	[LPS_(VF0561)]	 VFG049084(gb|YP_002920347.1) (wzt) lipopolysaccharide O-antigen ABC transport system ATP-binding component [LPS (VF0561)]
    BNHFPCLP_00685	1	894	+	(wbbN)	1-894/894	0/0	100.0	98.77	VFDB	VFG049051(gb|YP_002920344.1)	[LPS_(VF0561)]	 VFG049051(gb|YP_002920344.1) (wbbN) glycosyltransferase [LPS (VF0561)]
    BNHFPCLP_00686	1	1131	+	(wbbO)	1-1131/1131	0/0	100.0	99.47	VFDB	VFG049040(gb|YP_002920343.1)	[LPS_(VF0561)]	 VFG049040(gb|YP_002920343.1) (wbbO) glycosyltransferase family 1 protein [LPS (VF0561)]
    BNHFPCLP_00770	1	624	+	(rcsA)	1-624/624	0/0	100.0	100.0	VFDB	VFG049007(gb|YP_002920216.1)	[RcsAB_(VF0571)]	 VFG049007(gb|YP_002920216.1) (rcsA) transcriptional activator for ctr capsule biosynthesis [RcsAB (VF0571)]
    BNHFPCLP_01728	1	936	+	(iroE)	1-936/936	0/0	100.0	99.04	VFDB	VFG044322(gb|YP_002919453)	[Sal_(VF0563)]	 VFG044322(gb|YP_002919453) (iroE) siderophore esterase IroE [Sal (VF0563)]
    BNHFPCLP_02092	1	543	+	(sciN/tssJ)	1-543/543	0/0	100.0	99.45	VFDB	VFG048784(gb|YP_005226619.1)	[T6SS_(VF0569)]	 VFG048784(gb|YP_005226619.1) (sciN/tssJ) type VI secretion system lipoprotein TssJ [T6SS (VF0569)]
